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Objective: While shear stress closely regulates vascular remodeling, the mediators of this process have been only partially
elucidated. The current study examined the role of the gelatinases in flow-mediated vein graft intimal hyperplasia. We
hypothesized that matrix metalloproteinase (MMP)–2 and MMP-9 expression and protein levels, relative to tissue
inhibitors of metalloproteinase (TIMP)–1 and TIMP-2, are upregulated in a flow-dependent manner during vein graft
arterialization.
Methods: Bilateral common carotid interposition vein grafting was performed in rabbits. Reduction in flow was achieved
through unilateral ligation of the internal carotid artery and three of four branches of the external carotid artery. At 28
days grafts were harvested and analyzed for intimal area; MMP-2 and MMP-9, and TIMP-1 and TIMP-2 messenger RNA
content, via quantitative reverse transcription polymerase chain reaction; and MMP-2 and MMP-9, and TIMP-1 and
TIMP-2 protein concentrations, via both bioactivity assay and zymography.
Results: Branch ligation resulted in a 10-fold difference in mean flow rate and accelerated development of intimal
hyperplasia in a low-flow environment. Exposure of the vein graft to arterial hemodynamics induced a marked rise in
MMP-9 mRNA levels, whereas only a modest increase in MMP-2 mRNA was observed. MMP-2 protein was 50 to 100
times more abundant than MMP-9, and was significantly upregulated in grafts that demonstrated enhanced intimal
thickening. Immunohistochemistry demonstrated that MMP-2 was located throughout the myointima, whereas MMP-9
was localized almost exclusively to the region of endothelium. No differences in TIMP-1 and TIMP-2 mRNA or protein
levels were detected between high-flow and low-flow grafts.
Conclusion: MMP-2 is the predominate gelatinase that regulates early vein graft remodeling. Despite a marked increase in
MMP-9 gene expression, development of intimal hyperplasia after a reduction in wall shear rate correlates with an
increase in MMP-2 protein levels. These data suggest differential regulatory mechanisms for proteases within the
remodeling vein graft wall. Modulation of extracellular matrix biologic features may offer therapeutic strategies for the
prevention of vein graft failure. (J Vasc Surg 2004;39:1084-90.)Development of vein graft intimal hyperplasia is initi-
ated by the migration of smooth muscle cells (SMCs) into
the intima, and is sustained by the proliferation of these
cells in this subendothelial region.1,2 Breaching of the
internal elastic lamina and deposition of matrix in the
developing neointima are integral to this process.3 This
balance between matrix synthesis and degradation, as me-
diated by local protease activity, controls the rate and
magnitude of hyperplasia development.
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doi:10.1016/j.jvs.2003.12.0311084While many factors have been proposed to regulate the
architecture of vein grafts, biomechanical forces are integral
to the process.4,5 Vein graft adaptation under arterial forces
proceeds via a combination of intimal thickening and ex-
pansive remodeling, in which local alterations in wall shear
regulate the balance between these two processes and de-
termine the morphologic characteristics of the graft. Yet to
be fully elucidated are the mediators through which intimal
thickening predominates under reduced shear conditions;
yet expansive remodeling occurs in response to elevations
in shear.
Central to the degradation and reorganization of the
matrix are matrix metalloproteinases (MMPs), which reg-
ulate the process.6 The relative balance between activated
MMPs and their endogenous inhibitors, tissue inhibitors of
metalloproteinases (TIMPs), controls the reorganization of
the vein graft in response to exogenous stimuli.7 Gelatinase
A and B (MMP-2 and MMP-9, respectively), as a result of
their specificity for elastin and collagen, have been sug-
gested as important regulators of vein graft architecture.8
The current study examined the differential regulation of
the gelatinases and TIMPs in response to shear forces. We
hypothesized that MMP-2 and MMP-9 expression and
protein levels, relative to TIMP-1 and TIMP-2, are upregu-
nase.
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alization.
METHODS
Animal model. Eleven New Zealand White male rab-
bits (3.0-3.5 kg) underwent bilateral carotid interposition
vein grafting, with unilateral distal branch ligation, to cre-
ate defined regions of differential wall shear. Premedication
with ketamine (30 mg/kg intramuscularly) was adminis-
tered, endotracheal tubes were placed, and the rabbits were
anesthetized with isoflurane. Heparin (1000 units) was
administered intravenously, and the bilateral external jug-
ular veins and common carotid artery were exposed
through a vertical midline cervical incision. A 4-cm length
of each external jugular vein was harvested for creation of
the ipsilateral vein graft. Proximal and distal anastomoses
were created end-to-end with a cuff anastomotic technique.
For this procedure a rigid polyurethane cuff, fashioned
from a 4F vascular sheath (Terumo Medical Corp, Elkton,
Md) was used. The end of each jugular vein was passed
through a cuff, everted, and fixed with an 8-0 silk ligature.
A 2-cm longitudinal arteriotomy was created in the carotid
artery, and the cuffed ends of the vein were inserted in a
reversed configuration. A second 8-0 silk ligature was used
to fix the artery wall around each cuff, and the intervening
back wall segment of the carotid artery was excised. Unilat-
eral reduction in graft flow was accomplished through
placement of surgical clips, to completely occlude the in-
ternal carotid artery and three of the four primary branches
of the external carotid artery. Mean blood flow rate
through the vein grafts was recorded with an ultrasonic
flow meter (2.0-mm probe, T106; Transonic Systems,
Ithaca, NY), both before and after ligation of the distal
arterial branches.
After 4 weeks the animals were again anesthetized,
endotracheal tubes were placed, and heparin was adminis-
tered. Vein grafts were exposed through a midline neck
incision, and bilateral flow measurements were obtained.
Segments within 5 mm of the proximal and distal cuffs were
discarded, and harvested grafts were fixed in 10% buffered
formalin or frozen in liquid nitrogen for protein extraction
or messenger RNA (mRNA) isolation.
This study was performed after securing appropriate
institutional approval, and conforms with the Guide for the
Care and Use of Laboratory Animals (NIH Publ. No.
85-23, revised 1996).
RT-PCR primer and probe sequences
Forward primer Rev
MMP-2 5-AGAAGATCGACGCTGTG
TACGA-3
5-GGCTGAAT
TTCATTG-3
MMP-9 5-CCGGCATTCAGGGAGATG-3 5-TCGGCGTT
TIMP-1 5-CGCAGCGAGGAGTTTCTCA-3 5-CAAGTCGT
TIMP-2 5-GAGATCAAGCAGATCAAGA
TGTTCA-3
5-GGACGGCG
MMP, Matrix metalloproteinase; TIMP, tissue inhibitor of of metalloproteiMorphometry and wall shear analysis. Formalin-
fixed graft segments (n  22) were embedded in paraffin,
and histologic cross-sections were stained with Masson
trichrome and van Gieson elastic stains. Digitized images
were collected and analyzed to determine external elastic
lamina (EEL) length and neointimal cross-sectional areas
for each specimen. EEL diameters were calculated assum-
ing circular in vivo geometry:
Diameter  length/.
. Shear stress was calculated with the Hagen-Poiseuille
equation,   32 ·  · Q/ · d3, where  is mean wall shear
stress,  is the viscosity of blood (0.035 poise), Q is mean
flow rate, and d is the lumen diameter.
Real-time polymerase chain reaction. Quantitative
real-time polymerase chain reaction (RT-PCR) was per-
formed on paired vein graft segments (n  6). Total RNA
was isolated with TRI reagent and 1-bromo-3-chloropro-
pane phase separation according to the manufacturer’s
recommended protocol (Molecular Research Center, Cin-
cinnati, Ohio). After treatment with deoxyribonuclease I
(Ambion, Austin, Tex), reverse transcription was com-
pleted with random hexamers (PE Applied Biosystems,
Foster City, Calif) to obtain a final complementary DNA
concentration of 20 ng/L. TaqMan RT-PCR for the
genes of interest (Table) was performed with a 7700 Se-
quence Detection System (PE Applied Biosystems), using
200 nmol/L of forward primer, 200 nmol/L of reverse
primer, 50 nmol/L of probe, and 20 ng of cDNA per
25-L reaction volume, and TaqMan Universal PCR Mas-
ter Mix (PE Applied Biosystems). 18S RNA levels were
simultaneously determined on all samples for use as an
internal control. Both experimental and control samples
were assayed in triplicate. The Comparative Ct Method
(Ct Method; User Bulletin No. 2, PE Applied Biosys-
tems) was used for data analysis. Results are expressed as the
ratio of target gene mRNA copies to 18S ribosomal RNA
copies (106) to minimize variability from sample loading.
Quantification of total MMP. Paired segments of
vein graft (n  12) were extracted in 0.05 mol/L of Tris
(pH 7.5) and 0.2% Triton X-100, with a mortar and pestle.
Commercially available MMP-2 and MMP-9 activity assay
kits (Biotrack; Amersham Life Sciences, Piscataway, NJ)
were used to determine total (combined latent and endo-
genously active) enzyme concentrations, per the manufac-
turer’s protocol. Before analysis, assay samples were treated
rimer 6FAM-labeled probe
CCCAGTA 5-AGGAGGAGAAGGCCGTG
TTCTTTGCAG-3
AAAGTACG-3 5-TCGGCGTTTCCAAAGTACG-3
GTGCAAGAG-3 5-CGCTGGACAACTGCGGAACGG-3
TGTAGATG-3 5-AGGCCCCGACAAGGACATCGAGT-3erse p
ACA
TCC
GAT
CTG
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MMP-9) of p-aminophenylmercuric acetate; 50-100 L
sample) to activate latent enzyme. MMP-2 and MMP-9
sensitivity ranges were improved to 0.094 ng/mL and 0.31
ng/mL, respectively, by extending the primary incubation
time to 20 hours, as described in the manufacturer’s tech-
nical bulletin. Results are reported in nanograms of total
MMP (MMP-2 or MMP-9) per microgram of extracted
protein.
Zymography. Protein extraction from paired graft
specimens (n  12) was performed as above. Ten micro-
grams of protein was separated with 10% sodium dodecyl-
sulfate–polyacrylamide gel electrophoresis containing 0.1%
gelatin (Novex; Invitrogen, Carlsbad, Calif). Latent and
active forms of MMP-2 and MMP-9 (Oncogene, Cam-
bridge, Mass) were used as positive controls. Gels were
renatured and developed with commercially available buff-
ers (Novex). A digital image of the gel was acquired, and
band intensity was quantified with one-dimensional Image
Analysis Software (Eastman Kodak, Rochester, NY). Band
Fig 1. Effect of distal branch ligation on vein graft flo
post-ligation.
Fig 2. MMP-2 and-9 mRNA expression (left to right) for normal
vein, low-flow grafts, and high-flow grafts.intensity data are presented as the ratio of low-flow to
high-flow values.
Quantification of TIMP. Protein extraction was per-
formed as above. TIMP-1 and TIMP-2 commercially avail-
able enzyme-linked immunosorbent assay kits were used
according to the manufacturer’s specifications (Biotrack).
Because preliminary data demonstrated that TIMP-1 and
TIMP-2 concentrations were below the lower limit of the
assay, paired graft samples were pooled (10 g total protein
per sample) from five animals for analysis. Results are
reported in nanograms of TIMP (TIMP-1 or TIMP-2) per
microgram of extracted protein.
Immunohistochemistry. Formalin-fixed sections
were deparaffinized, rehydrated, and treated with MMP-2
(goat anti-human, 1:20; R & D Systems, Minneapolis,
Minn) or MMP-9 (goat anti-human, 1:100; R & D Sys-
tems) antibodies overnight at 4°C. Assay was completed
with the administration of the secondary antibody (rabbit
anti-goat), ABC reagent (Vector Laboratories, Burlin-
game, Calif), and 3,3-diaminobenzidine (DAB) as a chro-
mogenic substrate. Macrophages were localized with an
antibody to RAM-11 (1:200; DAKO, Carpinteria, Calif),
with a similar detection scheme. Cell nuclei were counter-
stained with hematoxylin.
Statistical analysis. All data are expressed as mean 
SEM. Differences in flow rate, shear stress, intimal area, and
total MMP-2 and MMP-9 and TIMP-1 and TIMP-2 levels
were evaluated with a paired Student t test (Sigma Stat,
version 2.0). Statistical analysis of band intensity ratios
(low-flow to high-flow) obtained at zymography was com-
pared with unity with an unpaired Student t test. Differ-
ences in gene expression were examined by comparing the
cycle number difference, calculated as the difference be-
tween the target gene cycle number and 18S cycle number,
for low-flow versus high-flow grafts with a paired Student t
test.
te (A), shear stress (B), and intimal area (C), 28 daysw ra
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Hemodynamic parameters and morphologic find-
ings. After placement of bilateral interposition vein grafts,
flow rate was approximately equal through both the left-
sided and right-sided grafts (Fig 1, A). The immediate
response to unilateral distal ligation was a marked reduction
in flow on the ligated side, with only a minimal compensa-
tory increase in flow on the contralateral side. This initial
10-fold difference in flow rate persisted until graft harvest
28 days later. The effect of these flow changes was a
fourfold difference in wall shear stress between the ligated
and contralateral grafts (Fig 1, B).
Corresponding to the reduction in wall shear was a
significant difference in intimal cross-sectional area at graft
harvest (5.0  0.9 vs 0.9  0.3 mm2; P  .0007; low-flow
vs high-flow grafts, respectively; Fig 1, C). No significant
difference in the extent of outward remodeling was ob-
served between the two groups (diameter of the external
elastic lamina, 4.7  0.4 vs 4.6  0.1 mm; P  NS;
low-flow vs high-flow grafts, respectively).
Gelatinase gene expression. Quantitative RT-PCR
was used to determine MMP-2 and MMP-9 mRNA expres-
sion, with mRNA copy numbers normalized to 18S ribo-
somal RNA (Fig 2). In freshly harvested segments of the
vein MMP-2 mRNA expression was substantially greater
than that observed for MMP-9. Notable differences were
also observed in vein grafts, where an approximate 150-fold
difference between MMP-2 and MMP-9 mRNA levels was
detected.
A significant increase in MMP-9 mRNA expression was
noted after placement in the arterial circulation for 28 days,
with a 40-fold increase in low-flow vein grafts (P .02) and
a 20-fold increase in high-flow vein grafts (P  .005).
In contrast, a modest twofold to threefold increase in
MMP-2 mRNA levels was noted on comparing vein grafts
with normal vein (P  NS), and no notable difference in
MMP-2 expression for low-flow versus high-flow vein
grafts was observed.
Fig 3. A, Total MMP-2 and MMP-9 concentration (a
high-flow grafts. B, Relative contributions of latent an
C, Representative zymogram demonstrates low-flow andGelatinase protein activity and localization. After
addition of p-aminophenylmercuric acetate to activate en-
dogenous metalloproteinases, total MMP-2 and MMP-9
levels were determined with a quantitative activity assay
(Fig 3, A). Corresponding to the observations for gelati-
nase gene expression, total MMP-2 protein concentrations
in normal vein and vein grafts were approximately 100
times greater than total MMP-9.
Vein grafts exposed to low-flow conditions demon-
strated a twofold increase in total MMP-2 protein concen-
tration, compared with high-flow vein grafts (P  .05) or
normal vein (P  .02). Total MMP-2 protein level in
high-flow grafts was not notably different from that in
normal control veins. No significant difference in total
MMP-9 protein concentration was observed among low-
flow or high-flow grafts or normal control veins.
The relative contributions of latent and active forms of
the gelatinases were evaluated with zymography, with data
expressed as a ratio of low-flow to high-flow values (Fig 3,
B). Corresponding to the significant increase in total
MMP-2 in low-flow grafts, a threefold increase in the active
form of MMP-2 was observed in low-flow versus high-flow
samples (P .05). Relative concentrations of pro–MMP-2,
pro–MMP-9, and active MMP-9 were not notably influ-
enced by changes in flow.
MMP-2 was identified uniformly within the myointima
of the vein grafts, with evidence of enhanced staining
within the endothelium (Fig 4). In contrast, MMP-9 was
almost exclusively localized to the endothelium. RAM-11
staining revealed only sporadic macrophages within the
intima-media (one or two per histologic section), demon-
strating that this cell type was not the source of MMP-9 at
28 days. No differences in staining patterns were identified
between vein grafts exposed to low or high flow.
TIMP gene expression and protein concentra-
tion. Vein grafts demonstrated modest increases in both
TIMP-1 and TIMP-2 mRNA expression over normal vein;
and latent forms) in normal vein, low-flow grafts, and
ive forms, expressed as ratio of low flow to high flow.
-flow grafts.ctive
d act
high
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(Fig 5, A). No differences in TIMP-1 or TIMP-2 mRNA
levels (Fig 5, A) or protein concentration (Fig 5, B) be-
tween grafts exposed to high or low flow were observed.
Fig 4. Localization of MMP-2, MMP-9, and RAM-11 in low-
flow (A, C, E, G) and high-flow (B, D, F, H) vein grafts. MMP-2
(C, D) is located uniformly in the myointima, with enhanced
staining in the endothelium. MMP-9 (E, F) is almost exclusively
localized to the endothelium. Only sporatic macrophages (G, H)
are identified, most frequently in the surrounding adventitia. No
difference in localization pattern was observed between low-flow
and high-flow grafts.DISCUSSION
We examined the relationship between flow rate, inti-
mal hyperplasia, and gelatinase activity during vein graft
remodeling. Consistent with the observations of other in-
vestigators, vein grafts exposed to low-flow conditions
demonstrated a marked increase in intimal area. Accompa-
nying this change was an increase in MMP-2, predomi-
nately in an active form. While an increase in MMP-9
mRNA expression was observed in both low-flow and
high-flow grafts, these changes did not translate into sig-
nificant increases in protein concentration.
SMCs within the wall of the vein are surrounded and
embedded by extracellular matrix. On transfer of the vein
to the arterial circulation for grafting, the combination of
local injury and exposure to altered hemodynamic forces
induces an array of signaling mechanisms, which lead to
migration and proliferation of the medial SMCs within the
developing intima. Essential to the initiation of this process
is matrix degradation and remodeling around the migrating
SMCs, and an increase in local MMP activity has been
suggested as pivotal in this event.6
Several investigators have examined the effect of flow
on arterial adaptation to alterations in shear. Through use
of an arteriovenous fistula, groups have demonstrated that
acute elevations in flow lead to an increase in active MMP-2
and MMP-9,9,10 with pharmacologic MMP inhibition pre-
venting outward remodeling of the artery in response to
this increased shear.9 Potentially conflicting is the observa-
tions of Godin et al,11 in which the mouse carotid artery
ligation model was used to examine MMP expression in
response to acute reduction in flow. These authors demon-
strated that reductions in flow induced a transient increase
in MMP-9 expression, peaking at 1 to 3 days, then a
delayed increase in MMP-2, starting at day 7 and extending
through day 28. Recent data from this group in MMP-9
knockout mice has demonstrated an essential role for
MMP-9 in the remodeling process.12 Lack of the early peak
in MMP-9 production resulted in a significant reduction in
later thickening of the intima. This temporal pattern of
MMP expression in these studies is consistent with our
28-day results in vein grafts, in which we observed an
elevation in MMP-2 activity without significant change in
MMP-9 activity. While studies in the mouse carotid artery
have suggested the importance of a multistep MMP recruit-
ment model,13 future studies are needed to evaluate the
early temporal changes that occur in MMPs, and in partic-
ular MMP-9, during vein graft remodeling. Balloon angio-
plasty, in combination with alteration in flow, has demon-
strated similar findings14. Angioplasty without changes in
flow induced no alteration in MMP-2 expression; however,
reductions in flow after balloon injury resulted in a signifi-
cant increase in MMP-2.
The expression of MMPs has also been examined after
transfer of a vein segment to the arterial system for bypass
grafting. These studies show that MMP-2 and MMP-9 are
increased in vein grafts; however, the temporal expression
of this increase has not been clearly defined.15-18 Expres-
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unclear; one study demonstrated an increase in both
TIMP-1 and TIMP-2 in vein segments maintained in static
culture,15 whereas no change in TIMP-1 was noted in in
vivo vein grafts.18 The only study to examine the effect of
flow on vein graft MMPs was by Patterson et al,19 in which
vein segments were placed in a blood-free perfusion circuit
for up to 7 days. Differing from the results we have seen in
rabbit vein grafts, these authors observed an elevation in
MMP-2 and MMP-9, as well as in TIMP-1 and TIMP-2.
Potentially conflicting results may be secondary to differ-
ences inherent in the ex vivo perfusion system, for example,
nonpulsatile hemodynamic environment, no blood-surface
interaction, and potential problems with delivery of nutri-
tion or gas exchange.
In summary, our results are the first to demonstrate
that the accelerated intimal thickening that results from a
reduction in wall shear is associated with an increase in
MMP-2, predominately in an active form. While an in-
crease in MMP-9 mRNA expression was observed in both
low-flow and high-flow grafts, these changes did not trans-
late into significant increases in protein concentration.
Overall, regulation of gelatinase activity in response to
altered wall shear occurs independent of altered TIMP
expression.
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